PD, PK, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

Study Title
Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors
Teva Identifier
NEUGR-005
ClinicalTrials.gov Identifier
NCT01940601
Study Status
Withdrawn
Trial Condition(s)
Solid Tumors
Interventions
Drug: Balugrastim | Drug: Filgrastim

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
2 Years to 17 Years
Trial Duration
09/01/2014 - 12/01/2015
Phase
Phase 2

Study Type

Interventional